The U.S. Food and Drug Administration (FDA) on Wednesday approved updated COVID-19 vaccines from Pfizer, Moderna and Novavax for all seniors aged 65 and older, while restricting access for younger adults and children to those with at least one high-risk health condition, such as asthma or obesity.
FDA Limits COVID Vaccine Access to Seniors, High-Risk Groups